Mateen Sara, Gandhi Vishal, Meyr Andrew J, Kwaadu Kwasi Y, Sethi Anish
Resident, Temple University Hospital, Philadelphia, PA, USA.
Department of Podiatric Surgery, Temple University School of Podiatric Medicine, Philadelphia, PA, USA.
Pain Rep. 2021 Feb 16;6(1):e900. doi: 10.1097/PR9.0000000000000900. eCollection 2021 Jan-Feb.
Chronic opioid use is unfortunately perceived among these postoperative patients, specifically within orthopedic surgery. Patients having orthopedic surgeries are at risk for becoming addicted to opioids, and one benefit of peripheral nerves blocks could be to provide an alternative mode of pain control. This study takes a retrospective look at the use of peripheral nerve blocks for pain control following surgery for isolated traumatic ankle injuries. We hypothesize that when peripheral nerve blocks are administered preoperatively to patients with closed ankle fractures, they will have overall better control of postoperative pain compared to patients who did not receive a peripheral nerve block.
The objective of this investigation was to evaluate the effect of preoperative peripheral nerve blockade on pain outcomes after ankle fracture surgery.
After approval from our institutional review board, a Current Procedural Terminology code search was performed of all patients within our institution over a 3-year data collection period (August 2016-June 2019). This resulted in 177 subjects who underwent isolated closed ankle fracture open reduction internal fixation (ORIF), of which 71 subjects met inclusion criteria.
Results of the primary outcome measures found no difference in the mean postoperative care unit (PACU) pain scores between the groups (2.39 ± 2.91 vs 3.52 ± 3.09; P = 0.1724) nor the frequency of those who reported only mild pain (63.0% vs 47.10%; P = 0.2704). Subjects who received a peripheral nerve block spent more time in the PACU before discharge (2.06 ± 1.05 vs 0.94 ± 1.21 hours; P = 0.0004). Subjects receiving a peripheral nerve block were more likely to be given no analgesics in the PACU (38.9% vs 11.8%; P = 0.042) and less likely to receive a narcotic analgesic in the PACU (53.7% vs 82.4%; P = 0.047).
Although the results of this investigation demonstrate no significant difference in the mean PACU pain scores, they do demonstrate a significant difference in the amount of pain medication given in the PACU setting. This information will be used for future investigations of this discrepancy between pain perception and need for immediate postoperative pain medications as it relates to multimodal pain control in the setting of ankle fracture surgery.
不幸的是,在这些术后患者中,尤其是骨科手术患者中,存在慢性阿片类药物使用的情况。接受骨科手术的患者有阿片类药物成瘾的风险,而外周神经阻滞的一个好处可能是提供一种替代的疼痛控制模式。本研究回顾性地观察了外周神经阻滞在孤立性创伤性踝关节损伤手术后用于疼痛控制的情况。我们假设,对于闭合性踝关节骨折患者,术前给予外周神经阻滞,与未接受外周神经阻滞的患者相比,他们术后疼痛的总体控制情况会更好。
本研究的目的是评估术前外周神经阻滞对踝关节骨折手术后疼痛结局的影响。
经机构审查委员会批准后,在3年的数据收集期(2016年8月至2019年6月)内,对本机构内的所有患者进行了当前操作术语代码搜索。这产生了177名接受孤立性闭合性踝关节骨折切开复位内固定术(ORIF)的受试者,其中71名受试者符合纳入标准。
主要结局指标的结果显示,两组之间术后护理单元(PACU)的平均疼痛评分无差异(2.39±2.91对3.52±3.09;P=0.1724),报告仅有轻度疼痛的患者频率也无差异(63.0%对47.10%;P=0.2704)。接受外周神经阻滞的受试者在出院前在PACU停留的时间更长(2.06±1.05对0.94±1.21小时;P=0.0004)。接受外周神经阻滞的受试者在PACU更有可能未接受任何镇痛药(38.9%对11.8%;P=0.042),而在PACU接受麻醉性镇痛药的可能性更小(53.7%对82.4%;P=0.047)。
尽管本研究结果表明PACU平均疼痛评分无显著差异,但确实表明在PACU环境中给予的止痛药物量存在显著差异。该信息将用于未来关于踝关节骨折手术中疼痛感知与术后即刻止痛药物需求之间差异的研究,因为这与多模式疼痛控制有关。